Surgical Pathology Cancer Case Summary

SKIN:             Report

SKIN: Resection

(Excludes Eyelid, Vulva, and Penis; excludes Melanoma)

MACROSCOPIC (check all that apply)

SPECIMEN TYPE

___ Elipse

___ Shavings

___ Curettings

___ Other (specify:____________)

TUMOR SITE: _______________

TUMOR SIZE: ___ (x___x___) cm

TUMOR FEATURES

___ Raised

___ Flat

___ Ulcerated

___ Unpigmented

___ Pigmented

___ Necrosis

___ Hemorrhage

___ Indeterminate

MICROSCOPIC (check all that apply)

HISTOLOGIC TYPE

EPIDERMAL CARCINOMAS

___ Basal cell carcinoma (BCC)

___ Superficial BCC

___ Nodular BCC (solid, adenoid cystic)

___ Infiltrating BCC

___ Sclerosing BCC (desmoplastic, morpheic)

___ Fibroepithelial BCC

___ BCC with adnexal differentiation

___ Follicular BCC

___ Eccrine BCC

___ Basosquamous carcinoma

___ Keratotic BCC

___ Pigmented BCC

___ BCC in basal cell nevus syndrome

___ Squamous cell carcinoma

___ Spindle-cell (sarcomatoid) SCC

___ Acantholytic SCC

___ Verrucous SCC

___ SCC with horn formation

___ Lymphoepithelial SCC

___ Papillary SCC

___ Clear-cell SCC

___ Small-cell SCC

___ Post-traumatic (e.g., "Marjolin's ulcer")

___ Metaplastic ("carcinosarcomatous") SCC

___ Paget’s Disease

___ Mammary Paget’s disease

___ Extramammary Paget’s disease

___ Adnexal carcinoma

___ Eccrine carcinoma

___ Sclerosing sweat duct carcinoma (syringomatous carcinoma, microcystic adnexal carcinoma)

___ Malignant mixed tumor of the skin (malignant chondroid syringoma)

___ Porocarcinoma

___ Malignant nodular hidradenoma

___ Malignant eccrine spiradenoma

___ Mucinous eccrine carcinoma

___ Adenoid cystic eccrine carcinoma

___ Aggressive digital papillary adenoma/adenocarcinoma

___ Apocrine carcinoma

___ Sebaceous carcinoma

___ Tricholemmocarcinoma

___ Malignant pilomatricoma (matrical carcinoma)

___ Merkel cell carcinoma

___ Mitotic activity <10 division figures per 10 high power

___ Mitotic activity ³10 division figures per 10 high power

HISTOLOGIC GRADE

___ GX: Cannot be assessed

___ G1: Well differentiated

___ G2: Moderately differentiated

___ G3-4: Poorly differentiated/undifferentiated

___ Not applicable

EXTENT OF INVASION

PRIMARY TUMOR (T)

___ TX Primary tumor cannot be assessed

___ T0 No evidence of primary tumor

___ Tis Carcinoma in situ

___ T1 Tumor < 2 cm in greatest dimension

___ T1a - limited to dermis or < 2 mm in thickness

___ T1b - limited to dermis and > 2 mm in thickness but < 6 mm in thickness

___ T1c - invading the subcutis and/or > 6 mm in thickness

___ T2 Tumor > 2 cm but < 5 cm in greatest dimension

___ T2a - limited to dermis or < 2 mm in thickness

___ T2b - limited to dermis and > 2 mm in thickness but £ 6 mm in thickness

___ T2c - invading the subcutis and/or > 6 mm in thickness

___ T3 Tumor > 5 cm in greatest dimension

___ T3a - limited to dermis or < 2 mm in thickness

___ T3b - limited to dermis and > 2 mm in thickness but < 6 mm in thickness

___ T3c - invading the subcutis and/or > 6 mm in thickness

___ T4 Tumor invades the deep extradermal tissue (eg, bone, cartilage, muscle)

___ T4a - < 6 mm in thickness

___ T4b - > 6 mm in thickness

REGIONAL LYMPH NODES (N)

___ NX Regional lymph nodes cannot be assessed

___ N0 No regional lymph node metastasis

___ N1 Regional lymph node metastasis

DISTANT METASTASIS (M)

___ MX Presence of distant metastasis cannot be assessed

___ M0 No distant metastasis

___ M1 Distant metastasis

MARGINS

___ Margins uninvolved by tumor

Distance of tumor from closest margin: __ cm

(Specify margin: ________________)

___ Margin(s) involved by tumor

(Specify margin: ________________)

BLOOD/LYMPHATIC VESSEL INVASION

___ Absent

___ Present

___ Indeterminate (see comment)

PERINEURAL INVASION

___ Absent

___ Present

___ Indeterminate (see comment)

ADDITIONAL PATHOLOGIC FINDINGS

___ Actinic keratosis

___ Bowen's disease

___ Other (specify) ____________________________________

COMMENTS

____________________________________________________

____________________________________________________

____________________________________________________

____________________________________________________